Related Experiment Video

Updated: Jul 18, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

Application of antisense technology to urologic cancers

Y Tomita1

  • 1Department of Urology, Niigata University Faculty of Medicine, Asahimachi, Niigata, Japan. ytomita@med.niigata-u.ac.jp

Molecular Urology
|May 15, 2002
PubMed

Insights

Antisense oligodeoxynucleotides (ODNs) offer a promising therapeutic approach by inhibiting target gene expression for diseases like cancer. Further advancements in ODN technology and delivery systems are crucial for realizing their full potential.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Antisense oligodeoxynucleotides (ODNs) are short nucleic acid sequences designed to bind to specific messenger RNA (mRNA) molecules.
  • This binding inhibits protein synthesis, thereby modulating gene expression.
  • ODNs have shown potential in treating various conditions, including malignancies.

Purpose of the Study:

  • To review the therapeutic potential of antisense oligodeoxynucleotides (ODNs).
  • To highlight the applications of ODNs in human diseases, particularly cancer.
  • To identify areas for future development in ODN technology and delivery.

Main Methods:

  • Literature review of existing studies on antisense ODNs.
  • Analysis of the mechanisms of action for ODN-based gene silencing.
  • Evaluation of current challenges and future prospects for ODN therapeutics.

Main Results:

  • Antisense ODNs effectively inhibit target gene expression.
  • ODNs are applicable to the treatment of human diseases, notably malignancies.
  • Significant improvements in ODN design and cellular delivery systems are required.

Conclusions:

  • Antisense ODNs represent a promising new class of therapeutic agents.
  • Continued research and development are necessary to overcome current limitations.
  • ODN-based therapies hold substantial promise for future clinical applications.

More Related Videos

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction06:01

Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction

Published on: October 6, 2022

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...